相关实验视频

Updated: Jun 9, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

PreserFlo MicroShunt 的术后结果在患有脱皮玻璃眼的患者中

Hiroyuki Wakuda¹, Ryota Aoki¹, Shunsuke Nakakura¹

¹Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji 671-1227, Japan.

Journal of clinical medicine

|October 26, 2024

概括

在48周的时间里,PreserFlo MicroShunt在亚洲患有脱皮绿内障的患者中显示出50%的成功率. 建议谨慎使用,因为在这个患者群体中,复手率为30%.

科学领域:

眼科医生眼科眼科
玻璃眼的手术玻璃眼的手术
医疗器械医疗器械

背景情况:

脱皮光眼是一种常见的二次开角光眼的类型.
玻璃眼瘤手术的目的是降低眼内压力 (IOP) 并防止视神经受损.
PreserFlo MicroShunt是一种用于管理耐火性玻璃眼的设备.

研究的目的:

评估PreserFlo MicroShunt在亚洲患有脱皮绿内障的患者的术后结果.
评估PreserFlo MicroShunt在这个特定的人群中的有效性和安全性.
为了确定程序后的成功率和重新操作率.

主要方法:

一组29名患有脱皮绿内障的亚洲患者接受了PreserFlo MicroShunt手术.
使用Kaplan-Meier生存分析来评估结果.
成功是通过IOP降低 (≥20%) 和目标IOP范围 (5-21,5-18,或5-15 mmHg) 来定义的,针刺和药物作为合格的成功.

主要成果:

平均随访时间为27.9周,复手率为31%.
在IOP条件下,24周的完全成功率从49%到56%不等.
在IOP条件下,24周的合格成功率从53%到67%不等.

结论:

在24周和48周,PreserFlo MicroShunt在亚洲患有脱皮绿内障的患者中显示出大约50%的成功率.
观察到大约30%的显著重新运行率.
建议在使用PreserFlo MicroShunt进行脱皮绿内障管理时谨慎考虑.

关键词:

脱皮玻璃眼玻璃眼玻璃眼玻璃眼的手术玻璃眼的手术在InnFocus中,我们将专注于一个微型的shunt.开放角格劳科马 (Open-Angle Glaucoma) 是一种眼睛上的光.花果料花果伪剥皮青光眼青光眼青光眼副结膜过手术是什么意思

更多相关视频

Iris Fixation via External Pentagram Suturing

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...